News for Amicus Therapeutics, Inc. (0HF9.L)

We recently published a list of 11 Best Guru Stocks to Buy According to Wall Street Analysts. In this article, we are going to take a look at where Amicus Therapeutics, Inc. (NASDAQ:FOLD) stands against other Guru stocks to invest in. Wall Street seems to be breathing a little easier after the initial panic over […]

Summary Amicus Therapeutics Inc (FOLD), a global biotechnology company dedicated to developing innovative medicines for rare diseases, has announced it will hos

We recently published a list of 10 Best Low Priced Growth Stocks To Invest In. In this article, we are going to take a look at where Amicus Therapeutics, Inc.

Low priced stocks usually fall under the small to mid-cap size category.

We recently published a list of 10 Best Low Cost Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Amicus Therapeutics, Inc. (NASDAQ:FOLD) stands against other best low cost stocks to buy according to billionaires. Markets are wobbling, and panic is becoming the headline. At times […]

Amicus Therapeutics, Inc. shows strong revenue growth with Galafold & Pombiliti driving potential $1bn by 2028. Click for my updated look at FOLD stock.

We recently compiled a list of the 12 Stocks Under $10 With High Upside Potential. In this article, we are going to take a look at where Amicus Therapeutics, Inc.

Significant Transaction by PERCEPTIVE ADVISORS LLC (Trades, Portfolio) On January 8, 2025, PERCEPTIVE ADVISORS LLC (Trades, Portfolio) executed a noteworthy tra

Amicus Therapeutics Inc (FOLD), a global biotechnology company dedicated to developing treatments for rare diseases, announced on February 27, 2025, that its ma

We recently published a list of the 10 Oversold Pharma Stocks to Buy According to Analysts. In this article, we are going to take a look at where Amicus Therapeutics, Inc.

Significant Acquisition by PERCEPTIVE ADVISORS LLC (Trades, Portfolio) On February 13, 2025, PERCEPTIVE ADVISORS LLC (Trades, Portfolio) made a notable addition

On February 19, 2025, Perceptive Advisors LLC made a significant move by acquiring an additional 5,028,033 shares of Solid Biosciences Inc (SLDB). This transact

The following slide deck was published by Amicus Therapeutics, Inc.

Amicus Therapeutics, Inc. (NASDAQ:FOLD) Q4 2024 Earnings Conference Call February 19, 2025 8:30 AM ETCompany ParticipantsAndrew Faughnan - Vice President,...

**media[544267]**

NEW YORK, Feb. 17, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating whether certain officers and directors of Ami

On December 31, 2024, Redmile Group, LLC (Trades, Portfolio) executed a significant transaction involving Zymeworks Inc (ZYME), reducing its holdings by 261,448

On December 31, 2024, Redmile Group, LLC (Trades, Portfolio) made a notable acquisition by purchasing 7,197,951 shares of Silence Therapeutics PLC. This transac

On December 31, 2024, Redmile Group, LLC (Trades, Portfolio) executed a significant stock transaction by acquiring an additional 13,427,917 shares of RAPT Thera